Please login to the form below
Lucid Group appoints new head of operations and facilities
Isabel Smith will work to improve the agency’s US and UK sites
Medical communications agency Lucid Group has appointed Isabel Smith as its head of operations and facilities, a role that will see her work to streamline and improve its US and UK business sites.
Smith’s new role will also see her facilitate its new agile working policy, which allows employees to request ad hoc, regulator or permanent mobile working arrangements.
She said: “I have joined Lucid at such an exciting time for its employees.
“I love the flexibility it offers, and my role will be pivotal in ensuring Lucid has the right environment and infrastructure to ensure everyone can execute the Lucid life they desire.”
Featured jobs
-
Account Manager
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Client Services Director - Digital MedComms
-
£60000 - £80000 per annum, Benefits: Pension, healthcare, dedicated training budget, regul
-
Account Director
-
£Competitive Salary
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Publications director
-
Competitive salary and bonus scheme
-
Account director
-
Competitive salary and bonus scheme
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Seattle Genetics wins FDA priority review for oral HER2 drug
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- BMS unveils long-term results for Opdivo in kidney cancer
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- J&J gets US backing for vaccine against coronavirus, christened Covid-19
- Novartis plans inclisiran trial in the UK
- Ex-Sandoz exec admits role in generic drug price-fixing plot
- Spotlight interview: 15 minutes on Independent Medical Education
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Merck’s Ebola vaccine wins approval in four African countries
- ReNeuron set for recovery after Woodford stake sale
- Servier and Oncodesign reach first milestone in Parkinson’s partnership
PMHub
Complete Medical Communications (CMC)
CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...
Latest intelligence
- Enabling market access through outcomes-based pricing
- Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
- 20 for 2020 – Five pharma companies to watch
- As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
- The growing clinical importance of patient-reported outcomes (PROs)
- Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Quick links
Infographics
